Answers are grounded in this paper and cite their sources.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: assess the effectiveness of PICC material and design in reducing catheter failure and complications. inserted central catheters (PICCs) are routinely inserted in adults and children who require intermediate intravascular therapy such as total parenteral nutrition (Russell 2014; Ullman 2017). PICCs are long (50 cm to 60 cm), flexible catheters usually constructed of polyurethane or silicone material. Typically inserted in the basilic, brachial or cephalic veins of the upper arm, the tip of the PICC terminates in a central vessel providing natural haemodilution of irritant infusates, such as chemotherapy. In recent decades, PICC use has increased due to perceived advantages in comparison to central venous catheters (CVCs), such as bedside placement by non‐medical staff and reduced complication profile during insertion (Bertoglio 2016; Chopra 2013a; Johansson 2013). PICCs are associated with greater patient‐reported satisfaction in adults requiring central venous access (Periard 2008). They have also been demonstrated to be a cost‐effective intervention, with the average cost of a PICC insertion estimated at USD 690 per patient (Periard 2008), compared to approximately USD 1500 for other central vascular access devices (Di Carlo 2012). However, despite these perceived benefits, PICC complications are common, with 30% of PICCs failing prior to the completion of therapy (Shen 2009; Ullman 2015).
No takes yet. Share an insight, caveat, or question.
Schults et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: